ITHUF (iAnthus Capital Holdings) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is iAnthus Capital Holdings ROE % Adjusted to Book Value?

iAnthus Capital Holdings's ROE % for the quarter that ended in Sep. 2024 was 0.00%. iAnthus Capital Holdings's PB Ratio for the quarter that ended in Sep. 2024 was N/A. iAnthus Capital Holdings's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was N/A.

iAnthus Capital Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for iAnthus Capital Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iAnthus Capital Holdings ROE % Adjusted to Book Value Chart

iAnthus Capital Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-182.93

-217.72

iAnthus Capital Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of iAnthus Capital Holdings's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iAnthus Capital Holdings's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where iAnthus Capital Holdings's ROE % Adjusted to Book Value falls into.

iAnthus Capital Holdings ROE % Adjusted to Book Value Calculation

iAnthus Capital Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

iAnthus Capital Holdings's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

iAnthus Capital Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of iAnthus Capital Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

iAnthus Capital Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iAnthus Capital Holdings Inc (OTCPK:ITHUF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

2IA:Germany IAN:Canada

Address

214 King Street, Suite 314, Toronto, ON, CAN, M5H 3S6

Website

https://www.ianthus.com

iAnthus Capital Holdings Inc owns and operates licensed cannabis cultivators, processors, and dispensaries throughout the United States. The company's operating segments include the Eastern Region and Western Region. It generates a majority of its revenue from the Eastern Region. The Eastern Region includes the company's operations in Florida, Maryland, Massachusetts, New York, New Jersey, Vermont, and its CBD business. Its Western Region includes the company's operations in Arizona, Colorado, and Nevada.

Executives

Proud Richard C. Jr.	director, officer: CEO and Director	8253 PARSONS PASS, NEW ALBANY OH 43054
Alexander Shoghi	director	SUITE 1550, 300 WEST 6TH STREET, AUSTIN TX 78701
John Alexander Paterson	director	2 WENDIGO WAY, TORONTO A6 M6S2T9
Gotham Green Partners Llc	10 percent owner	1437 4TH STREET, SANTA MONICA CA 90401
Philippe Faraut	officer: Chief Financial Officer	420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Kenneth W Gilbert	director	C/O THE WENDY'S COMPANY, ONE DAVE THOMAS BLVD., DUBLIN OH 43017
Julius Kalcevich	officer: Chief Financial Officer	420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Robert R Galvin	officer: Interim CEO and COO
Senvest Management, Llc	director, 10 percent owner, other: (See Remarks)	540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Marco Dattanasio	director	420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Scott Herman Cohen	director	420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Zachary Arrick	director	420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Mich J Mathews-spradlin	director	ONE DAVE THOMAS BLVD., DUBLIN OH 43017
Oasis Investments Ii Master Fund Ltd.	10 percent owner	UGLAND HOUSE PO BOX 309, GRAND CAYMAN E9 KY1-1104
Seth Fischer	10 percent owner	C/O OASIS MANAGEMENT (HONG KONG) LLC, 21/F MAN YEE BUILDING, 68 DES VOEUX ROAD, CENTRAL K3